Jeffrey Glenn

Track

Insider profile

Currently holds a position at Eiger BioPharmaceuticals Inc

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 71% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Eiger BioPharmaceuticals Inc March 22, 2016 -
Jeffrey Glenn's trades of Eiger BioPharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
31.97
Quantity 27,305 -20.9%
Value US$702,777
Transaction date
Purchase
Price
123.82
Quantity 46,736 -8.0%
Value US$3,352,420
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-27 2022-12-22
B Purchase
31,694 +2.4%
493.75
US$574,514 		31,694 +2.4% 493.75 US$574,514
2020-08-12 2020-08-12
B Purchase
27,305 -20.9%
31.97
US$702,777 		27,305 -20.9% 31.97 US$702,777
2020-08-12 2020-08-12
B Purchase
46,736 -8.0%
123.82
US$3,352,420 		46,736 -8.0% 123.82 US$3,352,420
2020-08-12 2020-08-11
B Purchase
5,000 +7.5%
11.49
US$57,464 		5,000 +7.5% 11.49 US$57,464
2020-03-17 2020-03-16
B Purchase
30,000 +82.5%
5.03
US$150,813 		30,000 +82.5% 5.03 US$150,813